Former Guild president appointed to inaugural biosimilars role
Former national president of the Pharmacy Guild of Australia, George Tambassis, has been appointed inaugural Chair of The Australian Biosimilars Academy Advisory Board.
The industry-led Advisory Board, initiated by Arrotex Biologics, said it is committed to the education, and advocacy for biosimilar and biologic medicines in community pharmacy.
In his role as Chair, Mr Tambassis will be charged with increasing both the uptake, and utilisation of, biosimilar medicines, through the provision of education, training, and advocacy.
“During my nine-year tenure with the Guild, I frequently discussed the role of biosimilars as our industry’s next wave of opportunity,” he said.
“I am therefore thrilled that my new role affords me the opportunity to spearhead the education and advocacy required to deliver biosimilars to community pharmacy.”
The Australian Biosimilars Academy said it plans to invite community pharmacy’s most influential leaders to join Mr Tambassis on the Advisory Board.
It will also form subsequent working groups such as the Professional Services Working Group, the Marketing Working Group, and the Communications Working Group to enhance education and advocacy among community pharmacy.
Arrotex Group General Manager, Marketing, Lisa Golden, Melbourne, welcomed Mr Tambassis to the helm of Advisory Board.
She said the introduction of the board reinforces a pharmacy-centric strategy for Arrotex Biologics.
“The current biosimilars landscape provides a tangible opportunity for community pharmacy, as witnessed by the recent success of our adalimumab biosimilars switch,” said Ms Golden.
“Through education, resources, and in-store support from Australia’s largest pharmacy field force, we anticipate ongoing growth across all of our adalimumab and etanercept biosimilars.”